FIELD: medicine. SUBSTANCE: method involves introducing Poludan mixed with autoplasma into the anterior chamber. It is also additionally subconjunctivally introduced, when mixed with blood. EFFECT: enhanced effectiveness of treatment; direct action upon the injured corneal endothelium; arrested inflammation processes. 1 tbl
Authors
Dates
2001-04-27—Published
2000-02-08—Filed